In the third episode of our special Surviving Sepsis Campaign guidelines review, Prof. Waleed Alhazzani continues to discuss antimicrobial therapy and covers principles of fluid management.
In the second episode of our insider’s review of the new Surviving Sepsis Campaign guidelines, Prof. Waleed Alhazzani guides us through the principles of antimicrobial therapy.
Prof. Waleed Alhazzani, one of the lead authors of Surviving Sepsis Campaign guidelines, gives us an insider’s view on SSC methodology and discusses main points concerning resuscitation.
Prof. Jonathan Sherbino talks about a practice-changing paper on the use of CT in subarachnoid hemorrhage, interpreting diagnostic test results, and migraine treatment in ED.
Prof. Paul O’Byrne talks about the new data from the 20-year-old START trial, which evaluated the benefits of early ICS introduction in patients with mild and mildest forms of asthma, and considers benefits and potential downsides of this approach in light of some new information.
Prof. Francois Caron continues the discussion on smoking cessation and explains the potential use of cytisine and e-cigarettes.
Prof. Jonathan Sherbino reviews the benefits and downsides of aggressive BP lowering strategies in patients with intracranial hemorrhage on the basis of the ATACH-2 trial.
Prof. Zainab Samaan explains what the EAGLES trial tells us about smoking cessation in patients with psychiatric disorders.
Prof. Sanjit S. Jolly explains what we’ve learned about thrombectomy in MI from the TOTAL trial and shares advice for noncardiologists approaching STEMI and NSTEMI.
Prof. Francois Caron explains how to approach a patient trying to quit smoking and what we have learned from the latest large-scale RCT about smoking cessation.
English
Polski
Español
українська